Through proteomics technology, we obtained the differential proteins after COE action on MHCC97-H cells, among which the erythropoietin-producing hepatocyte receptor A2 (EphA2) has received our attention because of its extensive involvement in the malignant biological behaviors of HCC. The gene discussed is EPHA2; the disease is hepatocellular carcinoma.